Cavitation Technologies (CVAT) Cash & Equivalents (2010 - 2026)

Cavitation Technologies has reported Cash & Equivalents for 17 years, with the latest figure at $45000.0 in Q1 2026.

• Quarterly Cash & Equivalents changed N/A year-over-year to $45000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $45000.0 (changed N/A YoY) and the FY2025 annual result came in at $249000.0, up 39.11% from the prior year.
• Cash & Equivalents advanced to $45000.0 in Q1 2026 per CVAT's latest filing, from $31000.0 in the prior quarter.
• Over five years, Cash & Equivalents peaked at $779000.0 in Q1 2022 and troughed at $7000.0 in Q4 2023.
• A 5-year average of $270357.1 and a median of $216000.0 in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents plunged 97.96% in 2023, then surged 9628.57% in 2024.
• Over 5 years, Cash & Equivalents stood at $343000.0 in 2022, then slumped by 97.96% to $7000.0 in 2023, then soared by 9628.57% to $681000.0 in 2024, then slumped by 95.45% to $31000.0 in 2025, then surged by 45.16% to $45000.0 in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $45000.0, $31000.0, and $30000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.